3M Drug Delivery Systems is currently seeking collaboration partners for its selegiline patch product. We have successfully evaluated the technical feasibility of transdermally delivering selegiline using 3M’s proprietary drug-in-adhesive technology and are prepared to continue with clinical evaluation.
Please contact us to find out more and learn about our flexible deal terms designed to meet your needs.
With more than 30 years of proven transdermal drug delivery experience, let 3M increase your probability of technical and commercial success with transdermally delivered selegiline.
